Japan Bank Lending Rises 2.6% In December

Overall bank lending in Japan was up 2.6 percent on year in December, the Bank of Japan said on Thursday, coming in at 509.555 trillion yen. That beat forecasts for an increase of 2.5 percent and was up from 2.4 percent in November. Excluding trusts, bank ... ( read original story ...)

Japan’s Bank Lending 2.6% vs. 2.4% forecast

Investing.com - Japan’s bank lending rose unexpectedly in the last quarter, official data showed on Wednesday. In a report, Bank of Japan said that Japan’s Bank Lending rose to a seasonally adjusted annual rate of 2.6%, from 2.4% in the preceding quarter. ( read original story ...)

Japanese striker Miura signs deal to play beyond 50th birthday

Yokohama will be able to count on the evergreen striker, who is set to play into his 50s after signing a deal to play in the 2017 J2 League season Japanese striker Kazuyoshi Miura will take his professional football career beyond his 50th birthday after ... ( read original story ...)

Moxy Tokyo Kinshicho Hotel Announced for November 2017

Tokyo-based commercial real estate developer Pacifica Capital K.K. has signed a management contract with Marriott International to open Japan’s first location for Moxy Hotels in November 2017. The property, to be known as “Moxy Tokyo Kinshicho Hotel ... ( read original story ...)

Japanese monkey tries to mate with deer

A male Japanese monkey has been filmed trying to mount and mate with a Sika deer. Researchers saw the primate attempting to mate with at least two deer in November 2015, during the macaque breeding season. The macaques regularly bathe in hot springs in ... ( read original story ...)

Osaka hospital discovers perforated intravenous drip bags

OSAKA – A hospital in Osaka said Wednesday it had found perforated intravenous drip bags that were to be used for patients, following fatal drip poisonings in September at a Yokohama hospital. Kitano Hospital in the city of Osaka said no patients were ... ( read original story ...)

ObsEva Initiates IPO Filing For Women's Reproductive Treatments

The institutional investors own 77.1% of the company's stock pre-IPO. ObsEva is developing a lead candidate, OBE2109, which it in-licensed from Kissei Pharmaceutical Co of Japan, for the treatment of endometriosis and uterine fibroids. Endometriosis is a ... ( read original story ...)

Tokyo stocks down by close on yen rebound

Tokyo stocks closed lower Tuesday as a rebounding yen hit exporters, while Toyota lost early gains driven by news of a major investment in the United States. After a public holiday Monday, the Japanese market dropped at the start as falling oil prices and ... ( read original story ...)

Japan's Takeda buys US cancer specialist Ariad for $5.2bn

Japanese pharmaceutical giant Takeda has agreed to buy US drugmaker Ariad Pharmaceuticals for $5.2bn (£4.3bn). Ariad specialises in making medicines for patients with rare forms of leukemia and other rare cancers. The takeover was approved by the boards ... ( read original story ...)